🔵 RESEARCH
Trial tests Vision Transformer AI for placenta accreta ultrasound diagnosis
A registered clinical trial is developing an end-to-end Vision Transformer system for ultrasound-based prenatal diagnosis of placenta accreta spectrum.
Transformer AI is moving past crowded radiology niches into high-acuity maternal-fetal imaging, a thesis test for specialty ultrasound verticals. But registration is intent, not evidence — accuracy claims await prospective, multi-center comparison against expert sonographers.
🔵 RESEARCH
Node-RADS pathologically validated against size criteria in nasopharyngeal carcinoma
A European Radiology study pathologically validated Node-RADS versus size-based MRI criteria for cervical lymph node metastasis in nasopharyngeal carcinoma staging.
Size-based criteria underdiagnose nodal metastasis, and structured reporting could standardize oncologic staging and AI training data. Caution: a single-disease cohort with pathology limited to sampled nodes says little about reproducibility across readers and centers.
🔵 RESEARCH
Study assesses LI-RADS v2024 response algorithm after HCC brachytherapy
A European Radiology study evaluated histopathological outcomes of CT-guided high-dose-rate brachytherapy for HCC against the LI-RADS Radiation Treatment Response Algorithm v2024.
Radiologists reporting treatment response in interventional oncology gain pathologic evidence for the updated algorithm. But validation likely rests on surgically fit patients with resected lesions — real-world predictive accuracy awaits multi-center, prospective reproducibility data.
🔵 RESEARCH
Paired study tests AI on point-of-care and standard breast ultrasound
A paired reader study compared AI performance on point-of-care versus standard breast ultrasound, targeting diagnosis in low- and middle-income settings.
AI software could unlock handheld POCUS as a breast imaging channel where cart-based systems can't reach, pressuring incumbents in emerging markets. Operationally, though, a reader study isn't deployment — connectivity, device standardization, and biopsy capacity remain unaddressed bottlenecks.
Acta radiologica (Stockholm, Sweden : 1987) · 2026-06-10
Read more →
🔵 RESEARCH
Trial evaluates AI transvaginal ultrasound classifier for endometrial cancer detection
A registered trial evaluates an AI classifier on transvaginal ultrasound for non-invasive detection of endometrial cancer and atypical hyperplasia in post-menopausal bleeding.
The high-volume post-menopausal bleeding workup is a wedge to displace biopsy and hysteroscopy with software-driven triage. Deployment is years away with no vendor partnership disclosed — an OEM embedding deal would be the first credible operational signal.
🟢 FUNDING
Butterfly Network joins TD Cowen investor call June 18
Butterfly Network announced it will participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026.
Butterfly is courting institutional growth investors, likely reframing its story around recurring software revenue rather than dilution-funded survival. Watch for guidance updates or a capital raise after the call confirming a fundraising-driven IR push.
Google News: POCUS point-of-care ultrasound · Thu, 11 Ju
Read more →
🩺 EDITOR’S TAKE — FOR CLINICIANS
Ultrasound AI is moving into women's health — placenta accreta, endometrial cancer, breast POCUS — but every result here is a registered trial or controlled reader study. Demand external validation and inter-reader data before changing referral patterns.
📊 EDITOR’S TAKE — FOR INVESTORS
AI vendors are staking claims in specialty ultrasound verticals where procedure-avoidance and reimbursement justify premium pricing, while Butterfly's TD Cowen appearance hints at a capital event to fund the handheld POCUS-plus-software thesis.
🏭 EDITOR’S TAKE — FOR INDUSTRY
Standalone AI classifiers in obstetric and gynecologic ultrasound will need OEM embedding to reach point-of-care workflows — following Samsung Medison's UK placement this week, expect ultrasound platform makers to compete on licensing and bundling deals.